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INTRODUCTION 
 
 
 
 
 
 
 
  
INTRODUCTION 
 
  The diabetes Mellitus is rapidly increasing in prevalence worldwide. 
Many people with diabetes develop complications that seriously affect their 
quality and length of life. 
 
 
Most common complications seen with them are foot ulcers and 
amputations. The diabetic foot is often an inching painless surprise  that holds in 
its dark portals a soon  rising flood of complications.  
 
 
It is a quiet dread of disability causing  recurrent  hospitalisation  and 
prolonged hospital stay mounting  impossible expenses.  
 
 
Foot  lesions in a person with diabetes is indeed an expensive proposal.  
 
 
The costs  of treating these complications account for about 25% of the 
hospital costs of diabetes.  The indirect costs in loss  of  eamings and 
productivity can only be guessed as  it is thought these amount to about 50% of 
the total direct costs  of treating the diabetes.  
 
 
While progress has been made in the treatment of diabetic foot ulceration  
particularly by the establishment of dedicated diabetic foot clinics which  have   
reduced bed usage by up to 38% there still remains much morbidity and 
mortality.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
AIM OF THE 
STUDY 
 
 
AIM OF THE STUDY 
 
AIM AND OBJECTIVE: 
 
This  study  was  done to  know  about  the  effect   of  split skin graft  graft in 
treating the diabetic foot ulcers.   
The objectives of this study are   
 
• To study the effect of split skin graft in the wound healing of diabetic foot 
ulcers 
• To know the length of hospital stay  
• To know the donor site infections.  
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 REVIEW OF LITERATURE 
 
DIABETIC  FOOT ULCERS  
DEFINITION : 
 
Diabetic foot ulcers are defined as full thickness wound below the ankle 
irrespective of the duration.  
 
Diabetic foot ulcers are wound that occur on the feet of the  people with  
type 1 and 2 diabetes mellitus. These ulcers  usually occur on the bottom of the 
foot.  
EPIDEMIOLOGY: 
 
The global burden of diabetes is projected to increase form the current  
246 million people to over 380 million people by the year 2025. 
 
Among the people with diabetes 15% will experience a foot ulcer in their 
lifetime. Foot ulceration with infection is one of the leading cause of 
hospitalisation for patients with diabetes mellitus . 
 
It is now appreciated that 15-20% of patients with such foot ulcers go on 
to need an amputation, especially  major lower extremity amputation. Similarly 
85% of major lower limb amputation  are preceded by a foot ulcer.  
 
Once one limb has been amputated not only is there an increased risk that 
the other limb will also require amputation but the patient’s 5 year survival rate 
is only about 30%. 
 
Since they are  the major cause of lower limb amputations in these people 
they should be treated aggressively in order to  have a better outcome.  
 
ETIOLOGY : 
 
It is firstly important to appreciate that the etiology of diabetic foot 
disease is truly multifactorial.  
 
Within any individual patient one  factor may predominate over all or 
some of the others  but generally foot disease arises from more than one cause.  
 
Diabetic foot ulcers are contributed by  
1. Sensory, motor and autonomic,  neuropathy 
2. Macrovascular  and Microvascular diseases  
3. Infections  
4. Connective tissue abnormalities  
5. Haematological disturbances.  
 
PATHOGENESIS: 
NEUROPATHIC ULCERS: 
Neuropathic ulcers may be  
Due to    –   Sensory  
- Motor  
- Autonomic  
 
CAUSES OF NEUROPATHY : 
 
There are essentially two theories as to the causation of  diabetic 
peripheral neuropathy- one related to metabolic  factors and the other associated 
with microvasular disease.  
 
The metabolic theory suggests that peripheral nerve damage arises from 
abnormalities of sugar-alcohol metabolism. Hyperglycemia results in increased  
levels of intraneural sorbitol which may be directly toxic to the neural tissue. 
 
Hyperglycemia also reduces the sodium-dependent uptake of myoinositol 
by competitive inhibition.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The reduction in myoinositol levels impair the action of the membrane 
bound sodium –pottassium dependent ATPase.  
 
This results in the reduction of activity of the sodium –potassium pump 
and a reduction of nerve conduction velocity.  
Hyperglycemia 
Increased cellular 
glucose 
Competitive inhibitions of 
sodium dependent myoinositol      
uptake  
Increased Sorbitol  
Direct Neurotoxicity  
Decreased Myoinositol  
Decreased Na-k  pump 
activity  
Impaired nerve conduct 
 
Microcirculatory changes also have an adverse effect on nerve 
metabolism as it is discussed below.  
 
EFFECTS OF NEUROPATHY : 
 
Loss of somatic sensation over the plantar aspect of the foot can lead to 
extrinsic neuropathic foot ulceration following trauma. The trauma can be 
varied – ill fitting footwear, thermal, foreign bodies in shoes and toenail cutting 
are merely examples. 
 
The initial trauma is often minor and a person with intact sensation would 
naturally tend to protect the injury until it is healed. 
  
In the absence of somatic sensation, however areas, which would 
normally be painful are not perceived as such so allowing tissue damage to 
continue, once started, an established ulcer is the end point of the this process.   
 
The  somatic motor neuropathy, results in weakness of the intrinsic 
muscles of the foot which  in turn allows abnormal movement of the small 
bones of the foot and joint subluxation  occurs. Weakness of foot ligaments due 
to abnormalities of collagen metabolism contributes to this effect.  
              Visceral sensory neuropathy recluces or abolishes proprioception. 
Though the early bony  deformity is small, as patient continues to walk, 
ligaments and joint capsules are stretched further and the bony structures of the 
foot are altered permanently.  
 
As time goes on  these changes lead to foot deformities such as a claw 
foot with   prominent metatarsal heads or a Rocker-bottom foot with collapse of 
the longitudinal arch and prominence of the tarsal bones. The inflammation of 
the subluxed joints leads to charcot’s arthropathy.  
 
HOW DOES AN ULCER FORM: 
 
The above bony changes produce localized  areas of high pressure on the 
sole of the foot particularly under the metatarsal  heads, on the tips of toes, on  
the heel and under the mid foot. 
 
  These high pressure areas are assoicated with ulceration around three 
quarters of neuropathic ulcers occur in the forefoot, while, the remainder occur 
under the midfoot and on the heel. 
 
The initial response to this high pressure is the formation of protective 
callus. In addition to the vertical load force resulting from the patient’s weight 
acting on the callus, the  transverse and longitudinal shear forces are also 
established.  
 
The shear forces particularly those in the longitudinal plane traumatise 
the subcutaneous tissues between the underlying bone and overlying callus 
producing cavities containing serum or blood.  
 
The  cavities under the callus coalesce and eventually the callus beaks 
down resulting in an ulcer. The breakdown tends to occur centrally and the 
defect in the callus is much  smaller than the cavity underneath.  
 
This pattern of deep tissue destruction preceding epithelial breakdown is 
typical of neuropathic ulceration and differs from most other foms of ulcer. 
 
Autonomic neuropathy also contributes to the formation of calluses 
through a reduction in sweating. Sweat contains keratinolytic enzymes which 
helps  break down of  hyperkeratotic areas.  
 
In their absence  the callus shows unimpeded growth. The absence or 
reduction of   sweating also results in skin that is dry, inelastic  and prone to 
trauma.  
 
 
 
 
 
 
       DIABETIC FOOT ULCER FORMATION 
 
 
 
 
 
 
 
 
 
 
 
 
 
STAGES OF ULCER FOFMATION 
      
 1.   CALLUS   FORMATION 
 2.  COLLECTION  BENEATH  THE  CALLUS 
 3.  BREAKDOWN  OF  CALLUS 
  4.  ULCER  
 
 
 
 
 
 
 
 
 
                               NEUROPATHIC ULCERS 
ISCHEMIC ULCERS: 
DIABETIC MICROVASCULAR DISEASE : 
  
There are structural abnormalities of the capillary basement membrane in 
diabetes. The basement membrane is thickened as part of the general 
abnormality of extracellular matrix components and its composition is altered 
by excessive glycosylation of collagen and  proteoglycans. 
 
   This  glycosylation   reduces the charge on the membrane . These 
changes may explain the increase in capillary permeability to highly charged 
molecules such as albumin.  
 
 It also affects transcapillary movement of leucocytes and 
macromolecules. Diabetics have shown to have abnormal function of increased 
flow through the distal arterio-venous shunts proximal to the dermal capillary 
bed.  
 
There is an increased capillary luminal diameter secondary to basement 
membrane thickening and there is also an increase in capillary flow.  
 Although there is, increased capillary flow  there is less ability to 
vasodilate and increase blood flow in response to various stimuli like trauma or 
infection. Furthermore the vasoconstrictor response to the vertical posture is 
reduced with the result that capillary pressure rises.  This increases edema 
formation with the effect of impairing tissue perfusion.  
 
Endothelial functions are also disturbed  in diabetes. There is normally a 
fine balance in favor of vasodilatation over vasoconstriction and an anti 
thrombotic tendency brought about by reactions involving nitric oxide  
(Endothelium derived relaxing factor). Diabetes impair this function of the 
endothelium, which results  in impaired microcirculation. 
 
 All of the above changes seen  in the diabetes have a real  effect on tissue 
perfusion and potentially play an important role in ulceration. 
 
DIABETIC  MACROVASCULAR DISEASE  : 
 
Diabetes are four to seven times more prone to atherosclerosis than non – 
diabetics and the process appears to be accelerated in  diabetic patients requiring 
vascular surgery are therefore likely to be younger than non – diabetics. 
 
 Atherosclerosis in diabetes is the same condition as it is in the absence of 
diabetes, where it differs is in the prevalence and distribution of disease.   
 
Atherosclerosis  tends to  affect the tibial and peroneal arteries in diabetes 
in contrast to non – diabetics where the affected vessels tend to be above the 
knee. This difference in disease distribution demands more distal bypasses.  
 
 One caveat to this is vascular calcification. The media of arteries in 
diabetes tends to become calcified, often in excess of the degree of 
atherosclerosis that is present. The calcification is often visible on plain  
radiography or an angiography. 
 
While this calcification per se does not result in vascular obstruction, it 
increases the impedance of the vessel can making  surgery difficult and makes 
measurement of ankle brachial indices unreliable. Thus the  ankle brachial 
indices in these patients are unreliable.  
 
 The pressure required to obliterate the Ankle-Doppler signal in such cases is 
often falsely high and in some patients it is not possible to obliterate the signal.  
 
 A more realistic measure of perfusion pressure may be obtained by using 
toe digital   artery pressure the vessels  within the toes can be spared the effects 
of calcification.  
 It may be thought  that measurement of tissue oxygen partial pressure would 
overcome these difficulties of non-invasive arterial pressure assessment. 
  
If  there is any doubt regarding the peripheral circulation in a diabetic 
patient, angiography can  be performed.  
 
NEURO ISCHEMIC ULCERS:  
 Neuro ischemic ulcers (Mixed Etiology ulcers) have both neuropathy and 
ischemia.  
 
INFECTION:  
Infection is not generally a primary cause of foot lesions  in diabetes with 
the exception of  fungal  infection between the toes which can lead to skin 
breakdown and secondary bacterial infection.  
 
Once a lesion has developed infection plays an important role in 
determining its outcome whether the primary etiology is neuropathic, ischemic 
or a combination of the two. (ie neuroischemic lesion)  
 
There are several reasons for an increased propensity to infections  in 
diabetes.  
 
These include abnormalities of the inmune system with deficiencies in 
cell mediated immunity, impaired leukocyte chemotaxis, phagocytosis 
intracellular bactericidal activity and serum opsonization.  There is reduction of 
granulcyte motility and activity.  
 
The infection is virtually always polymicrobial with gram positive and 
gram Negative aerobes and anaerobes including staphylococcus aureus, 
Bacterioides, Proteus, Enterococus, Clostridia and Escherichia coli being 
present.  
 
Bacteria that overcome the host defences quickely colonise the wound, 
increasing in density until their cell signailing increases and gene expression 
alters.  
 
This bacterial response produces a three- dimensional polysaccharide 
matrix, forming a ‘BIOFILM’ which increases virulence, lessens the host 
response to infection and thereby increasing the antimicrobial resistance.  
 
This ‘BIOBURDEN’ may be responsible for delayed wound healing 
where bacterial numbers reach “CRITICAL COLONISATION’ with no overt 
host responses  when the ‘Bioburden’ reaches beyond the point of critical 
coloinsaiton. (105 bacteria/g) and bacterial invade the tissues causing direct cell 
damage.  
Necrotic tissues  should be debrided to reduce the bioburden . similarly 
infected bone requires proper surgical debridement to enable healing.  
 
When infection is secondary to a primary neuropathic or ischemic lesion 
it may remain superficial and localized.  
 
A Spreading cellulitis can also  develop however or the infection can 
spread into the deeper tissues. Drainage is the most problematic in neuropathic 
ulcers with a small defect in the overlying callus.   
 
If this defect is blocked a either by hyperkeratinization or by inspissated 
contents, then the infection is direly to spread into the deeper tissues and bones. 
This may results in abscess formation or osteomyelitis. 
 
In this way infection is responsible for most of the tissue destruction seen 
in complicated diabetic foot lesions. It’s actually a vicious cycle which helps in 
spreading the infection to surrounding areas, by compromising the blood flow 
due to edema formation. 
 
The small vessels  within this area are prone to thrombosis and occlusion 
as a results of sluggish flow due to platelet and leucocyte adhesion to vessel 
walls. These two  factors may combine to  produce localized tissue ischemia 
and even gangrene particularly in presence of macrovascular disease.  
 
CONNECTIVE TISSUE ABNORMALITY: 
The hyperglycemia of diabetes can significantly affect the structure   and 
functions of proteins. This is most commonly brought about by non –enzymatic 
glycosylation, a process in which glucoses first  binds reversibly with amino 
groups  on proteins. These then irreversibly bind more glucose to form 
advanced glycosylation end products.  
 
These can then form covalent cross –links with amino groups on others 
matrix proteins or on extravasated plasma proteins. These reactions are seen 
with haemoglobin , where the glycosylated product is hemoglobin AIc – a well 
known marker of the plasma glucose level over the previous 6 weeks.  
The structural  proteins collagen and keratin are all affected. As a results 
the inter-molecular cross linking produces tissues that are rigid, inflexible and 
resistant to digestion by proteases.  
 
The rigidity  of the subcutaneous tissue between the  callus and 
underlying bone renders it more likely to be torn by the shear forces referred 
above. The resistance of the keratin to keratinases   helps explain the production 
of callus both at sites of high pressure and at edges of open ulcers.   
 
The protein cross linking makes this callus hard and at the edge of an 
ulcer which delays the wound healing by preventing wound contraction.  
 
The collagen of the ligaments and joint capsules of the foot is affected in 
the sameway. These structures then become weak and inelastic and the process 
contributes to the deformation of the bony structure of the foot.  
 
HAEMATOLOGICAL DISTURBANCES 
 
Rheological abnormalities in diabetes contribute to ischemic ulcer 
formation and to the spread of infection. Red cells are less deformable possibly 
due to glycosylation of their cell membrane. 
 
 This along with a tendency towards hypercoagulability and increased 
plasma viscosity may play a part in reducing capillary circulation so 
contributing to any  ischemia  that is present.  
FOOT DEFORMITY 
 
     
 
 
 
 
 
 
 
 
X-RAY SHOWING FOOT DEFORMITY 
 
 
 
 
 
 
 
 
 
 
“AT RISK FOOT” 
All diabetics should undergo daily examination of their feet, either by 
themselves or by a relative, and especially by a trained health care professional.  
 
The examination is done to assess the degree of risk of developing foot 
ulceration. This introduces the concept of the ‘at risk’ foot. Assessing this 
degree of risk is central to the examination of a diabetic patient. 
 
 
During this assessment, attention must be paid to determining the 
presence and degree of  
• Neuropathy, 
• Peripheral vascular disease 
• History of previous ulceration  
• Foot’s appearence   
 
With this information a patients foot can be described as normal, 
ischaemic, neuropathic or neuroischemic. This is essential for appropriate 
treatment plan.  
 
 
 
 
 
NEUROPATHY : 
 
Neuropathy may be tested by the traditional clinical methods examining 
the various sensory modalities, muscle power and the knee and ankle reflexes.  
 
The pain sensation can be assessed with nylon monofilaments and 
vibration sense with a biosthesiometer. 
 
Nylon monofilaments are 5-10cm lengths of nylons of two differing 
thicknesses one which will buckle when a load of 80g is applied and the other at 
10g. 
 
The 10g  monofilament is pressed onto the skin fo the foot until it buckles 
if the patient is unable to feel this then it is assumed that protective sensation is 
lost. If the paitent is unable to feel the 80g monofilament then a severe 
neuropathy is present. 
 
 
 
 
 
 
 
  
             TEST TO FIND  OUT THE SENSATION 
 
 
 
 
 
 
 
 
 
 
The biosthesiometer allows the vibration perception threshold to be 
measured . The device  is placed on the great toe tip or onto a malleolus and the 
voltage increased until the patient can feel the machine vibrating. A threshold 
greater than 25v indicates significant neuropathy.  
 
PERIPHERAL VASCULAR DISEASE:  
 
Peripheral vascular status is assessed clinically by eliciting any history of 
claudication or rest pain and  by examination of foot pulses and any foot colour 
changes, with elevation  and dependency.  
 
The presence of gangrene and the appearance of any ulcers  are noted. 
This is supplemented by Ankle Brachial pressure index (ABPI) measurements.  
 
    However upto 10% of diabetic patients will have falsely high ABPI 
due to vascular calcification in the arterial media and so caution is required in 
their interpretation.   
 
Absence of foot pulses make peripheral vascular disease likely and the 
foot is labeled as ischemic 
 
If there is any doubt aobut the blood flow of the foot, Doppler study, 
duplex scanning and angiography can be done  to know the adequacy of the 
blood flow. Magnetic Resonance angiography may demonstrate a patent vessel 
not seen on catheter angiography.  
 
TRANSCUTANEOUS OXYGEN PRESSURE MAPPING: 
              Transcutanous oxygen pressure (TcPo2) mapping can be used to 
determine the severity of foot ischemia, thus aiding selection of appropriate 
treatment and decreasing the total cost of care. 
 
             Studies show that if  transmetatarsal (TcPo2) level is 30mm Hg or 
greater treatment should be conservative comprising  local wound care, 
debridement or a more minor ablative procedure. If the transmetatarsal (TcPo2) 
level is below 30mm Hg it will  anticipate the need for vascular reconstruction.  
 
 
 
 
ANGIOGRAPHY: 
 
    Angiography remains the gold standard for assessment of the lower 
arterial system prior to any intervention. It can be performed via femoral or 
brachial catheterization, with iodine based contrast used to visualise the blood 
vessels.  
 
MAGNETIC RESONANCE ANGIOGRAPHY: 
 
Magnetic resonance angiography (MRA) is likely to be the future 
investigation of choice. Current systems give clear visualisation of vessels  
above knee level but tend to give rather fuzzy images of crural vessels 
distally.Diabetic patients with poor renal function may benefit form MRA.  
 
MR   imaging is also extremely valuable as it  shows even early  
infection, with changes in bone marrow, edema of soft tissues, cavitations and 
sinus formation.  
 
PREVIOUS ULCERATION:  
 
Previous ulceration is one  of the most significant risk factors for the 
development of subsequent ulcers. 
A careful history regarding the development of  location, treatment and 
eventual healing of the ulcer will give strong pointers as to its etiology and to 
the pattern of possible future ulceration.  
 
FOOT APPEARENCE : 
 
The feet should be examined for any change in shape which may lead to 
the development of areas of high pressure,  prominent metatarsal heads, hammer 
toes or a collapsed midfoot.  
 
 
Such areas may be identified by the presence of callus or by excessive 
wear on the sole of the shoe at that site. These areas are particularly prone to 
ulceration and should be watched carefully. 
 
 Any dryness of the skin is also noted .The toes and interdigital spaces are 
examined for  fungal infection and for small ulcers which may not be 
immediately apparent. 
 
 The shoes should be looked at to  determine their fit and any  sites which 
may rub. Because ill-fitting shoes can produce Bunions,  Hammertoes, 
Callouses,  Blisters, Ulcers.            
 
 
RISK ASSESSMENT:  
 
  It is useful to stratify the information obtained and grade the degree of 
risk of ulcer development for individual patients.  
 
This helps determine how intensive foot observation  has to be and can  
impress on   high risk patients the need for vigilance.The following is a 
pragmatic stratification   
 
RISK OF ULCER  DEVELOPMENT  FOR  INDIVIDUAL PATIENTS 
FEATURES  LOW RISK  MODERATE 
RISK  
HIGH RISK  
Sensation  
Vascularity  
History  
Appearence  
Vision / Mobility  
Normal  
Palpable pulses  
No previous ulcer  
No deformity 
Normal  
Neuropathy or/ 
Absent pulses  
No previous ulcer  
No deformity 
Normal 
Neuropathy or/ 
Absent pulses 
Previous ulcer  
Deformity  
Impaired, with 
any of the above  
 
 
 
CLASSIFICATION OF DIABETIC FOOT ULCERS: 
There are various classifications they are :   
(i) WAGNER MEGGITT CLASSIFICATION  
(ii) UNIVERSITY OF TEXAS  SYSTEM CLASSIFICATION  
(iii) BRODSKY DEPTH ISCHAEMIA CLASSIFICATION  
The most common classification followed is WAGNER – MEGGITT    
CLASSIFICATION.  
 
 
 WAGNER  MEGGITT CLASSIFICATION 
 
 
GRADES 
Grade O 
Grade 1 
 
Grade 2 
 
 
Grade 3 
 
Grade 4 
Grade 5 
 
ULCERS 
Preulcerative lesion  
Partical thickness wound upto but not through the 
dermis  
Full thickness wound extending to 
Tendons are deeper subcutaneous tissue but  
without bony involvement or osteomyelitis  
Full thickness wound extending to and involving 
the bone  
Localized gangrene  
Gangrene of the  whole foot  
 
GRADING OF DIABETIC ULCER 
UNIVERSITY OF TEXAS SYSTEM CLASSIFICATION 
 
STAGE O 1 2 3 
A Pre / Post 
ulcerative lesion. 
Completely 
epithelialised  
Superficial wound 
not involving 
tendon, capsule 
bone 
Wound 
penetrating 
to tendon or 
capsule  
Wound 
penetrating 
to bone or 
joint 
B  +Infection  +Infection  +Infection  +Infection  
C +Ischemia   +Ischemia  +Ischemia   +Ischemia  
D +Ischemia   
and infection  
+Ischemia and 
infection  
+ Ischemia 
and Infection  
+ Ischemia 
and 
Infection  
 
BROAKSKY DEPTH ISCHEMIA CLASSIFICATION 
This is a modification of WAGNER MEGGITT CLASSIFICATION 
BASED ON DEPTH : 
GRADES  
 
O  - Previous ulcer / Neuropathy with deformity that may cause new  
ulceration  
 
1 - Superficial ulceration not infected 
2 - Deep ulceration exposing a tendon/ joint  
3 - Extensive ulceration with exposed bone and / or deep infection  
(eg. Osteomyelitis, abscess) 
 
 
 
 
 
 
ISCHEMIA CLASSIFICATION:  
 
A - Not Ischemia 
B - Ischemic without gangrene 
C - partial gangrene of the foot 
D - Complete foot gangrene with grades 1-3 
 
PRESENTATION OF DIABETIC FOOT: 
 
There is a spectrum of presentation of diabetic foot problem ranging from 
a mere pain to gangrene. They are :  
(i) Pain in the foot 
(ii) Sores, ulcers, Blisters 
(iii) Absence of sensation   
(iv) Absence of pulsation in the foot 
(v) Loss of joints movements  
(vi)  Abscess formation  
(vii) Change in colour and temperature when gangrene sets in  
(viii) Patient may succumb to ketoacidosis septicemia, or myocardial 
infarction.  
 
 
 
 
 
 
 
INVESTIGATIONS:  
The investigations are done  to improve the general condition of the 
patient, to  attain glycemic control, to control the infection, to assess the 
vascularity of the leg  and for appropriate management.  
 
They are  
• Complete Dblood count  
• Blood glucose  
Fasting 
Postprandial  
• Renal parameters  
• Wound culture and sensitivity  
• X-ray foot (osteomyelitis,  foot deformity)  
• Chest X-ray 
• Cardiac evaluation –ECHO  
• Doppler study  
• Duplex scanning, angiography – Adequate blood  flow 
• CT scan /MRI (to see for pockets of pus / abscess)  
• TREATMENT : 
 
 Here again we have so many options like medical management  surgical 
interventions and also includes the patients education .  
These are  
 
ANTIBIOTICS: 
It is effective when the infection is local or superficial. The choice of  the 
drug should take account of the polymicrobial nature of these lesions.  
Currently, no specific antibiotic regimen has superior for treating these diabetic 
foot infections. 
 
 Clinical trials suggest that fluroquinolones, cephalosporins, beta-lactam 
inhibitor penicillins, and carbapenams are effective . 
 
   The following drugs can be used depending upon the degree of 
infection and pathogens. 
 
  For mild infections drugs like cephalexin 250-500 mg qid, cefazolin 1-2 
g iv tds or ampicillin-sulbactam 3 g iv qid or amoxicillin-clavulanate 
(augmentin) can be used. 
 
For complicated cases who are treated as in-patients who have both 
aerobes and anaerobes organisms , drugs like ciprofloxacin750 mg bd with 
metronidazole 500  mg tds or clindamycin 300 mg qid can be used. In severe 
cases  fourth  generation  cephalosporins  like  cefotaxime  2 g iv, ceftriaxone 2 
g iv with metronidazole 500 mg iv or piperacillin-tazobactam 4 g iv or 
ticarcillin-clavulanic acid 3 g iv tds can be used. 
 
   For patients with  life threatening infections imipenam500 mg iv qid or 
meropenam 1 g iv tds or vancomycin 1 g with aztreonam 2 g iv tds with 
metronidazole 500 mg iv or clindamycin or fourth generation cephalosporins 
can also be used. 
 
 OFF LOADING AND PRESENT APPLIANCES :  
Removing or re-distributing mechanical force’ off  loading’ – from a 
diabetic foot is an important factor in wound care and can alter skin physiology.  
 
Orthotics play a very important role in achieving the healing of 
neuropathic ulcer by providing the footwear which reduces the pressure at the 
site of ulceration.There are several devices and techniques used for off loading:  
1. Clinical padding , such as semi compressed  felt 
2. Orthotic management using various types of foam sponge which can be 
added to pre-fabricated insoles used in clinic or layered in bespoke 
insoles.  
3. Footwear  with adjustable insoles such a the ‘DH boot’ 
4. Total contact castings (TCC) is a specialist technique using felts, 
stockinette, plaster of paris bandage and fiberglass plaster, to prevent 
movement at  the ankle and transfer the weight to the lower leg. 
5. The Scotch cast boot is similar to the TCC, but finishes below the ankle 
and after contains a’ window’ in the cast 
6. Pneumatic walker (Air cast) is a full length plastic boot that works in a 
similar way to TTC, using internal balloons to achieve weight transfer.  
7. Pressure Relieving Ankle Foot Orthotic (PRAFO) is a device  for  off 
loading utilizing a metal  frame with adjustable strapping and footing.   
8. Charcot’s Restraint Orthotic Walker (CROW)  is removable lined , 
plastic full lengths boot which is moulded to a cast of the patient’s leg 
and foot. It tend to be used for patients with foot deformity. 
9. Crutches, Zimmer frames or wheelchairs can be used to aid off loading  
under the supervision of  a physiotherapist.  
 
                 CONTACT   PLASTER   CAST 
 
                     DIABETIC    SHOE 
 
 
 
 
 
 
 
 
 
 
DIABETIC    SHOE 
 
 
Diabetic shoes, sometimes referred to as extra depth or therapeutic shoes, 
are specially designed shoes or inserts intended to reduce the risk of skin 
breakdown in diabetics with co-existing foot disease 
 
The primary goal of therapeutic footwear   is to prevent complication 
such as strain ulcers, calluses or even amputation for patients with diabetes and 
poor circulation.  
The shoes must be prescribed by the physician and fit by a qualified 
individual such as certified pedorthist 
 
The shoes must also be equipped with a removable orthotic foot. 
Orthotics are devices such as shoe inserts, arch supports, or shoe filters such a 
lifts, wedges and heels. 
  
The  diabetic shoes help these patients to avoid foot injuries and improve 
mobility.  
 
Types of shoes: 
There are two types of diabetic shoes. 
1. CUSTOM MOLDED  
2. DEPTH SHOES 
Custom molded shoes are shoes that are:  
• Constructed over a positive model of the wearer’s foot 
• Made from leather or other material of equal quality  
•  Have removable inserts  that can be altered or placed as the wears’ s 
condition warrants  
•  Have some form of shoe closure such as lace or  Velcro   
 
Depth shoes  are  shoes  that  
• Have a full length  heel to toe liner that when removed provides a 
minimum of 3/16 inch of additional depth used to accommodate 
custom molded or customized inserts.  
• Made from leather or other material of equal quality  
• Have some form of shoe closor, such as lace or Velcro  
•  are available in full and half sizes Velcro with a minimum of three 
widths.  
 
DRESSINGS : 
 
Although a wide variety of dressings are available none is particularly 
superior to any other with the possible exception of enzymatic preparation 
(Streptokinase). 
 
The important principle is that the dressing should absorb any exudates 
which may be produced and it should be non adherent.  
HYPERBARIC OXYGEN:  
     In an hypoxic environment wound healing is halted by decreased 
fibroblast proliferation collagen production and capillary angiogenesis.  
 
Hypoxia also allows growth of anerobic  organisms further complicating 
wound healing. Hyperbaric oxygen therapy(HBO)  provides a siginificant 
increase in tissue oxygenation in the hypoperfused infected wounds.  It 
influences the rate of collagen deposition angiogenesis and bacterial clearance 
in wound. The greatest benefits are achieved in tissue with compromised blood 
flow and oxygen supply.  
 
IN DIABETIC PATIENTS: 
The increased wound oxygen tension achieved with HBO promotes 
wound heating. Increases the host atimicrobial defenses and has a direct 
bacteriostatic effect on anaerobic microorganisms.  
 
TREATMENT:  
Patients undergoing hyperbaric oxygen therapy rest in a chamber which is 
pressurized to 2-3 times the atmospheric pressure with 100% oxygen for a 
duration of 90 to 120 minutes. The initial treatment is dictated by the severity of 
the disease process. 
In the presence of limb-threatening infection, after debridement or 
compromised surgical flaps following amputation the patient should be treated 
twice daily.  
 
When the infection in under control and the soft tissue envelope improves 
once daily treatment are adequate. 
 
This increases the patients haemoglobin and plasma oxygen 
concentration. Thus poorly perfused tissues receive increased oxygen reducing 
ischemic damage and promotes microvascular angiogenesis. It also helps in 
fibroblast division necessary for matrix formation.  
 
 
 
 
 
 
THE ROLE OF CHIROPODY: 
 
In addition to cutting toenails and foot inspection for medium and high 
risk patients  removal of callus is an important part of diabetic foot treatment. 
This in done with a scalpel and has been such to reduce the pressure exerted at 
these sites.  
 
By doing this the risk of ulcerations  is  reduced.  Padding for prominent 
areas or overlapping toes is provided. If a neuropathic ulcer develops then 
removal of callus form its edge is important to allow free drainage and also to 
enable wound contraction because the callus can be so hard as to prevent this. 
SURGICAL PROCEDURES:  
 
Certain factors in wound healing can be altered through surgical 
interventions. Diabetic foot ulcers  are chronic ulcers, which are actually 
difficult to be treated  
 
SURGICAL GOALS : 
The following are the goals of surgery in treating  the diabetic foot ulcers. 
(i) Reduces the risk of ulceration /Amputation  
(ii) Reduces the foot deformity 
(iii) Provide stable  foot for ambulation  
(iv) To reduce the  pain 
(v) Improve the appearence of the foot 
 
The following are the surgical interventions done in these patients to 
promote the wound healing.  
1. Wound debridement  
2. Reconstructive procedures Flaps/ Skin grafts  
3. Endovascular procedures  
4. Bypass procedures  
5. Amputation.  
 
 
WOUND DEBRIDEMENT: 
 
Debridement is carried out  mainly in patients with deep ulcers often 
associated with tissue necrosis and  abscess  formation. 
 
So there is a need to open all the deep abscesses and excise all the 
necrotic tissue. Along with this broad spectrum intravenous antibiotics are 
required.   
 
RECONSTRUCTIVE FOOT SURGERY : 
 
Certain factors in wound healing can be altered through the  surgical 
interventions.  
 
In principle the primary benefit of reconstructive surgery for non healing 
wounds is the introduction of tissues  with good vascular supply to deliver 
oxygen, nutrients and growth factors.  
 
For reconstructive purpose, either flaps or skin grafts are used depending 
on the nature of  the wound.  
 
Management of soft tissue defects of the foot demands attention to  
specific features of regional anatomy and function as well as general principles 
of wound repair.  
 
In diabetes Mellitus, devotion to these basic principles is crucial. The 
effects of neuropathy, peripheral  vascular disease, and susceptibility to 
infection manifest as increased risk of skin ulceration and decreased capacity for 
wound healing . 
 
The complex wounds encountered  in patients with diabetes may contian 
exposed bone or  tendon or they may lie in  weight bearing areas of the foot . 
 
Thus by placing the flaps / grafts it will reduce the wound  tension and 
provide mechanical and thermal protection as well as hydration.  
 
(i) FREE FLAP TRANSFER: 
 
Flap covers are mainly done in regions of weight bearing areas of the foot 
[eg heel of the foot] with larger defects where skin grafts are not possible. This 
micrvascular free tissue transfer may allow wound  healing and hence helps in  
limb preservation.  
 
 
This  may also  be combined with arterial revascularisation procedure. 
The advantage of this techniques is that it provides immediate soft tissue 
coverage, limiting the amputation level and improving the healing time resulting 
in early ambulation. The following are the types of flaps.   
 
THE TYPES OF FREE TISSUE TRANSFER ARE  
1. FASCIOCUTANEOUS FLAP  
Free radial forearmflap  
Free lateral arm flap  
Free tenosr fascia latae flap 
 
 
2. MUSCLE FLAP WITH OVERLYING SKIN GRAFT 
 Free rectus abdominis muscle flap  
 Free gracilis muscle flap  
 Free latissimus flap  
 Free serratus anterior flap  
 Free vastus lateralis flap   
 
                                   SKIN GRAFTS 
 
Skin grafts are appropriate for partial thickness wounds or for deeper 
wounds that are well perfused. Sis Astely Cooper was the first to perform 
successful skin graft in 1817.  
 
TYPES OF GRAFTS  
• PARTIAL THICKNESS SKINGRAFTS  
• FULL THICKNESS GRAFTS  
• COMPOSITE GRAFTS   
A.PARTIAL THICKNESS SKIN GRFATS (SPLIT SKIN GRAFT ): 
 
Also called as THIERSCH graft. Split skin graft consist of epidermis 
and a variable thickness of dermis. There remains some dermis on the donor site 
that  heals by epithelialisation from the cut ends of  hair follies and sweat glands 
in a manner similar to the healing of a superficial burn.  
 
PROCEDURE : 
 
The thigh is most frequently used as a donor site, but almost anywhere 
else can be used. Grafts are harvested using   a skin graft knife or a  called as 
HUMBY’S KNIFE or a power dermatome and a guard that can be adjusted to 
determine the thickness of the graft.  
 
This graft may be thin or thick. The survival  of the graft on  the recipient 
area is known as  TAKE. 
 
STAGES OF GRAFT TAKE: 
STAGE OF PLASMATIC IMBIBITION:  
A uniform layer of plasma forms between recipient bed  and the  graft  
 
STAGE OF INOSCULATION : 
Linking of host and graft which is temporary 
 
STAGE OF NEOVASCULARISATION:  
New capillaries proliferate into the  graft from the recipient bed which 
attains circulation later. 
 
TECHNICLA ASPECTS : 
 
Since a graft in contrast to the flap does not derive its blood supply from 
the  donor site it must depend on the vascularity of the recipient  site.  
 
As noted even tendon with intact paratenon and bone with periosteum 
will take a skin graft. It can not be applied over bare bone or bare tendon or 
cartilage.  
 
 
  
 
 
 
 
     HARVESTING SKIN GRAFT FROM THIGH 
                         PRE AND POST OPERATIVE PICTURES 
 
POST OPERATIVE PICTURES 
POST OPERATIVE PERIOD : 
 
Post operatively, the percentage  of graft taken are assesed during the 
fifth day initially and the donor  site is also examined on the tenth day for  any 
signs of infection.   
 
B.FULL THICKNESS GRAFTS : 
 
It is also called as WOLFE GRAFT. It includes both the epidermis and 
full dermis. Here  donor site is closed by primary suturing  
 
C.COMPOSITE GRAFT : 
 
Composite grafts consists of skin and some underlying tissue such as fat 
or cartilage.  
 
PREOPERATIVE REQUIREMENTS : 
 
Preparation of a wound for surgical repair requires  attention to several 
factors that may be contributing to impaired healing.  
 
These include infection, vascular insufficiency, neuropathy and edema. 
Systemic factors such as inadequate controls of blood gulcose or nutritional 
deficits should also be corrected.  
As with any wound a foot wound in a patient with diabetes should be 
debrided of infected and necrotic tissue. This is usually accomplished most 
efficiently by sharp excision.  
 
 
VASCULAR RECONSTRUCTIVE  PROCEDURES: 
 
The following are the procedures  done in patients with poor vascularity. 
These procedures help in preventing amputation by restoring the blood flow or 
it avoids high level of amputations. They are in the form of either endovascular 
therapy, by pass surgery or a combination of both . 
 
(i) ENDOVASCULAR PROCEDURES : 
 
Endovascular  procedures which are usually done are balloon angioplasty 
with or  without stent placement. They are mostly used for inflow vessels  and 
femoro popilteal lesions.  
 
         Currently , stents are metallic and permanent and may be self  expanding 
or require balloon expansion.  
 
       Balloon angioplasty for distal poplitieal and crural run-off  vessels  is 
achievable using a small balloon for a short stenosis.   
 
 
 
(ii) BYPASS SURGERY: 
 
               Distal bypasses  onto tibial or pedal vessels are often required .   In-
flow  vessels  disease is common in diabetic patients. 
 
               In a recent study diabetic patients comprised a greater proportion of 
the total number of patients requiring in-flow bypass as well as a greater 
proportion of patients requiring subsequent outflow bypass for unresolved  
ischemic symptoms.  
 
  Inflow  reconstruction can be achieved surgically with an aorta- 
bifemoral or axillo-bifemoral bypass in cases of bilateral disease.                     
Femoro-Femoro crossover  or ilio-femoral bypass can be used in unilateral 
disease. Femoral endartectomy  , with or without a profundoplasty, remains a 
very useful simple procedure. Autogenous vein   should be used whenever 
possible . 
 
 
The results of  by passing in patients with diabetes are as good as those in 
non diabetics.  
 
 
 
 
AMPUTATION: 
Amputation is done in limbs which are not salvagabel.  Amputations of 
lower extremities can be classified into major limb amputation and foot 
amputation Major limb amputations can be above knee or below knee with trans 
femoral, Gritti- stokes and knee disarticulation.  
 
Foot amputations can  be  a done alone or in combination with by pass 
surgery These are classified as ray amputation for toe necrosis, chopart’s mid 
tarsal amputations, lisfranc’s  tarso-metatarsal joint amputation, syme’s 
amputation or through ankle. 
 
Total calcanectomy is described as an alterative procedure to trans-tibial 
amputation in patients with chronic osteomyelitis of the calcaneus, achieving 
eradication of infection and the preservation  of improved functional 
ambulation. 
 
  NEW TRENDS 
New methods which are followed recently are as follows,  
1) REMOVAL OF NECROTIC TISSUE WITH DESLOUGHING 
AGENTS :  
 
                            Hydrocolloids ,larvae,  enzymes  
 
SCHEMATIC REPRESENTATION OF  
MANAGEMENT OF DFU   
 
 
 
 
2) MANAGING EXUDATES: 
Polyurethane foams, capillarity dressing, kerraboot, vacuum assisted 
closure (VAC),  alginates, cellulose composites, non adherent dressings, film 
dressing  
 
3) SKIN EQUIVALENTS: 
                          Allograft (cultured keratinocytes, or fibroblasts) 
                         Xerografts  
                         Bioengineered skin 
   
4) GROWTH FACTOR: 
Platelet devived growth factor PDGF  
 
5)AIDING CELL MOTILITY:  Hyaluronan   
6) REDUCING THE BACTERIAL BIOBURDEN: 
  Topical antiseptics, topical antibiotics, honey, chlorhexadine charcoal-
based dressings.  
 
LATEST PRODUCTS : 
 
1) SILVER IMPREGNATED DRESSINGS : 
 
With the evolution of organisms with multi resistance of antibiotics, the 
introduction of silver impregnated dressings have emerged. 
 Silver can be added to many dressing types. Thereby combining the 
effectiveness of the dressing with antimicrobial activity .  
 
  2)    THE KERRABOOT: 
 
The kerraboot is a non contact wound care device comprising a plastic 
boot with a super absorbant foot pad . It maintains warmth and moisture at the 
wound site necessary to promote angiogenesis and epithelialisation.  
 
Odour is virtually eliminated by use of a ‘trapping’ layer foming part of 
the boot’s overall construction.  
 
PREVENTIVE MEASUERS: 
 
The following are some of  the preventive measures to be followed by the 
diabetic  patients  to prevent ulcer formation or any major complications 
 
• Cleansing the feet and keeping it dry 
• Check the feet for any ulcers /sores  
• Check for the sensation of the foot 
• Properly fitting shoes  
• Avoid smoking  
• Regular exercise 
• Removal of the callus.  
• PATIENT’S EDUCATION: 
 
Patient education is central to the management of the diabetic foot with 
the emphasis on prevention. The importance of daily self examination and  
careful hygiene is stressed along with the need for good, well fitting shoes with 
sufficient depth.  
 
The patient should always look and feel in the shoe before putting it on 
in case any object has fallen in which may cause foot trauma.  
 
Patients with foot deformities should have shoes which accommodate 
the foot without creating abnormally high pressure areas. This may mean simple 
obtaining extra depth shoes or formally fitted orthoses may be required.   
Hand cream without perfume or colouring should be used daily or twice 
daily to prevent dry skin from cracking  
 
Toenail cutting should only be carried out by patients if they are low risk, 
for the all others regular chiropody is advised 
 
 
 
 
 
 
 
 
 
 
 
 
MATERIALS AND 
METHODS  
 
 
 
MATERIALS AND METHODS 
 
 This is a prospective study conducted on 20 patients with diabetic foot 
ulcers who have undergone split skin  graft procedure in the surgical department 
of Kilpauk Medical College and Hospital during the period of September 07- 
August 09. 
  
Detailed History of the patients and thorough clinical examination was 
done in all cases. Documentation was done using a stratified proforma which 
included dermographic data of the patients studied. For all patients 
hematological , biochemical, microbiological and radiological investigations 
were carried out as enumerated in the proforma. Blood sugar both fasting and 
postprandial were done. Renal parameters were also done. X ray of the affected 
foot, Chest Xray, ECG and cardiac evaluation were done. The vascular status of 
the patients were also assessed.  
 
Wound preparation was done for all the patients by wound debridement, 
all the patients were put on broad spectrum antibiotics according to their 
respective wound culture reports. Their glycemic status was assessed and all of 
them were put on Injection. Human insulin both monotard and actrapid 
according to their blood sugar level. After getting assessed by the anesthetist 
they were taken up for surgery- Split Skin Graft.  
Post operatively, on fifth day, the graft take percentage was assessed 
followed by on tenth day. On tenth day, the donor site was also examined for 
any infection. The results were analysed. 
 
The mean stay of the patiens in the hospital during the preoperative and 
postoperative period were also analysed  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
  RESULTS AND  
OBSERVATION  
 
 
RESULTS AND OBSERVATION 
 
 20 patients with diabetic foot ulcers have undergone split skin graft after 
attaining all the preoperative requirements of which the percentage of graft take 
was assessed during the fifth and tenth post operative day, and the length of the 
stay in the  hospital during the pre operative and post operative period were 
assessed.The donor site infections were also observed. The following results 
were observed.  
 
ON THE FIFTH POSTOPERATIVE DAY 
NO OF PEOPLE SHOWED 100% GRAFT TAKE 
 
 
100% graft take  
Male Female  T Frequency   
6 7 13 65% 
 
 
NO. OF PEOPLE SHOWED 99% GRAFT TAKE  
 
 
 
 
 
99% graft take  
Male  Female  T Frequency   
2 0 2 10% 
  
 
 
FIFTH POST OPERATIVE DAY 
   
 
 
 
 
FIFTH POST OPERATIVE DAY 
  
 
 
 
 
 
OF PEOPLE SHOWED 98% GRAFT TAKE 
 
 
 
 
 
NO
. OF PEOPLE SHOWED 97% GRAFT TAKE  
 
 
 
 
 
 
 
 
 
 
98% graft take  
Male  Female  T Frequency   
1 1 2 10% 
 
97% graft take  
Male  Female  T Frequency   
2 1 3 15% 
  
 
 
 
 
FIFTH POST OPERATIVE DAY  
  
 
 
FIFTH POST OPERATIVE DAY 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
ON THE TENTH POSTOPERATIVE PERIOD 
NO. OF PEOPLE SHOWED 100%  GRAFT TAKE  
 
 
N
O. OF PEOPLE SHOWED 99% GRAFT TAKE  
 
100% graft take  
Male  Female  T Frequency   
9 7 16 80% 
 
99% graft take  
Male  Female  T Frequency   
2 2 4 20% 
  
 
 
 
 
 
 
TENTH POST OPERATIVE DAY 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
TENTH POST OPERATIVE DAY 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
LENGTH OF STAY  IN  THE  POSTOPERATIVE PERIOD 
 
          Average no of days of  stay in the  hospital  in  the postoperative period 
- 13 days  
 
No. of. Days of stay No. of . people Frequency 
M F T 
10 2 1 3 15% 
11 1 0 1 5% 
12 3 6 9 45% 
13 2 1 3 15% 
15 1 0 1 5% 
16 1 1 2 10% 
20 1 0 1 5% 
 
 
 
 
 
 
 
  
POST OPERATIVE HOSPITAL STAY
  
 
 
 
GH OF HOSPITAL STAY IN THE PREOPERATIVE PERIOD 
 
No. of. Days of stay No. of . people Frequency 
M F T 
<10 1 1 2 10% 
11-20 3 3 6 30% 
21-30 3 1 4 20% 
31-40 4 3 7 35% 
61-70 0 1 1 5% 
Average No.of Days of  Hospital stay-26.15 days 
 
      Average no days of hospital stay in the pre operative period is 
26.15 days 
 
 
 
 
 
  
 
 
 
PRE. OPERATIVE PERIOD 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
DONOR SITE INFECTION 
 
 
No. of . Patients showed minimal donor site infection -3 
Soner site infection  No. of . patients  Frequency 
M F T 
Seen 2 1 3 15% 
Not seen 9 8 17 85% 
 
 
  
 
 
 
 
 
 
 
 
DISCUSSION 
 
 
 
 
 
 
 
 
DISCUSSION 
 
In this prospective study conducted on 20 patients with diabetic foot 
ulcers, who have undergone split skin graft, we are able to observe  the 
following results.   
 
The percentage of graft take the length of hospital stay and donor site 
infectionS  were assessed from  the study. It was found that 65% of patients  
showedd 100% graft take on the fifth  postoperative day, followed by 10% of 
patients showed 99% graft take on fifth post operative day. Another 10% of 
patients showed  98% graft take on fifth  post operative  day and 15% of 
patients showed 97% graft take on the fifth postoperative day.  
 
From the study it was observed that 80% of patient showed  100% graft 
take on tenth post operative day  and 20% of them showed 99% graft take on 
tenth post operative day.  
 
According to the literature, 80% of patients have  shown 100% graft take 
on fifth postoperative  day and   remaining 20% of patients have shown 100% 
graft take on second week of surgery.  
 
From the above study it was observed that the length of stay in the 
postoperative period has come down to aobut 50% of the preoperative stay.  
In the preoperative period, the average number of  days of hospital stay 
was about 26.15 days whereas in the postoperative period it was about 13 days. 
According  to the literature the preoperative stay is about 21 days and the 
postoperative stay in the hospital is about 12 days.  
 
 
From the above study it was found that 15% of paitents showed minimal 
donor site infections. According to the literature it is about 10%. This were the 
results observed. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
CONCLUSION 
CONCLUSION 
 
 
As we know that the prevalence of the diabetes mellitus is increasing 
world wide and many people with diabetes develop the foot ulcers, which are 
difficult to heal on its own due to the various etiological factors and it has 
become the major cause of long hospitalisation and it also  casts an economical 
burden for both the hospital and the individual.  
 
It is important to treat these ulcers earlier to prevent major complication 
like amputation. Certain factors can be altered by surgery to promote the wound 
healing. One such procedure is this application of split skin graft.  
 
 From this study we could observe the effect of split skin graft in 
promoting the wound healing and it has also shown to reduce the length of 
hospital stay thereby it reduce the expenses spent on treating these ulcers.                    
Moreover it  helps the patient to walk again and also prevents major 
complications.         
                                                                                                                        
From the above study, it was observed that the length of hospital stay in 
the post operative period , has came down to about 50% of the preoperative  
operative. 
 
As per the literatwe, the mean post operative stay is about 12 days. In the 
above study it was observed that 45% of patients have stayed for 12 day in the 
hospital after surgery.  
 
Among the patients in this study group, it was observed that 15% of 
patients  have shown minimal donor site infection. According to the Literature it 
is about 10% 
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 CLINICAL PROFORMA 
NAME  
AGE 
SEX  
IPNO 
D.O.A 
D.O.S 
D.O.D 
DURATION OF STAY  
        PREOPERATIVE PERIOD 
        POST OPERATIVE PERIOD 
HISTORY  
        ULCER 
             SPONTANEOUS / TRAUMATIC  
             SITE OF ULCER  
H/O CLAUDICATION   
PREVIOUS H/O ULCER  
SMOKING H/O 
ALCOHOL H/O 
FAMILY H/O DIABETES MELLITUS  
TREATMENT FOR DIABETES MELLITUS  
LOCAL EXAMINATION OF ULCER  
         ULCER  
                  SITE  
                  SIZE 
                  EDGES 
                 MARGIN  
                 FLOOR  
                 BASE  
       COLOUR OF THE FOOT  
      ANY DEFORMITY OF FOOT  
PERIPHERAL PULSES  
INVESTIGATIONS 
               HB% 
               TC 
               DC 
              ESR 
               BT  
               CT 
BLOOD SUGAR  
        FASTING  
      POSTPRANDIAL  
BLOOD UREA 
SR. CREATININE  
URINE – ALBUMIN  
             SUGAR 
             ACETONE  
WOUND – CULTURE AND SENSITIVITY  
CHEST X-RAY  
X-RAY FOOT  
- ANTERO POSTERIOR VIEW 
- OBLIQUE VIEW 
ELECTRO CARDIOGRAM 
ECHO  
TREATMENT – SPLIT SKIN GRAFT 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
MASTER CHART 
 
 
 
 
 
 
 
 
 
 
 
KEY TO THE MASTER CHART 
A   Absent 
P  Present 
M Male 
F Female 
FOD Family H/O Of Diabetes 
DOA Date of Admission 
DOS   Date of Surgery 
DOD Date of Discharge 
PGT Percentage  of Grafttaken 
DSI  Donor site infection       
POD   Post operative day 
NS Notseen         
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                                           MASTER CHART 
S.No IPNO NAME AGE SEX FOD DOA DOS DOD 
PGT 
DSI Pre OS POS 5 POD 10 POD 
1 8435 Anand 50 M A 24/9/2007 8/10/2007 18/10/2007 99 100 NS 38 10 
2 1387 Paneersel vam  55 M A 19/1/2008 30/1/2008 11/2/2008 100 100 NS 13 12 
3 9218 venkatesan 50 M A 2/5/2008 23/5/2008 3/6/2008 100 100 NS 20 11 
4 6053 Kuppan  51 M A 22/3/2008 17/4/2008 2/5/2008 97 99 NS 40 15 
5 19463 Mani 56 M P 7/9/2008 14/10/2008 30/10/2008 98 100 MSI 36 16 
6 4409 Sarabee 60 F P 21/0/2008 4/4/2008 15/4/2008 98 99 NS 15 12 
7 25027 Sasi 35 F A 18/11/2008 20/11/2008 8/12/2008 100 100 NS 7 12 
8 20935 Rukmani  45 F A 26/9/2008 4/11/2008 18/11/2008 100 100 NS 38 13 
9 17195 Shanihi 60 F A 10/8/2008 18/10/2008 3/11/2008 97 99 NS 68 16 
10 517 Prema 60 F P 19/9/2008 23/11/2008 4/11/2008 100 100 NS 34 12 
11 10441 Revathy 40 F P 20/5/2008 2/6/2008 14/6/2008 100 100 NS 12 12 
12 1515 Gangammal  40 F A 29/1/2008 3/3/2008 4/3/2008 100 100 NS 33 12 
13 9456 Gopal 45 F P 5/5/2008 11/6/2008 24/6/2008 100 100 NS 36 13 
14 3277 Hariram  40 M A 14/2/2009 13/3/2009 23/3/2009 100 100 NS 23 12 
15 15327 Ramasamy 60 M A 8/7/2009 29/7/2009 18/8/2009 97 99 MSI 21 20 
16 19407 Chittibabu  45 M P 19/8/2009 12/9/2009 24/9/2009 100 100 NS 21 12 
17 19290 Sekar 45 M A 18/8/09 31/8/2009 13/9/2009 100 100 NS 13 13 
18 1387 Premkumar  55 M A 20/1/09 30/1/2009 9/2/2009 99 100 NS 10 10 
19 2904 Amsa  37 F P 10/2/2009 2/3/2009 14/3/2009 100 100 NS 19 12 
20 604 Vasantha  40 F A 8/1/2009 4/2/2009 14/2/2009 99 100 NS 26 10 
 
